182 related articles for article (PubMed ID: 26829886)
1. D-Allose Inhibits Cancer Cell Growth by Reducing GLUT1 Expression.
Noguchi C; Kamitori K; Hossain A; Hoshikawa H; Katagi A; Dong Y; Sui L; Tokuda M; Yamaguchi F
Tohoku J Exp Med; 2016 Feb; 238(2):131-41. PubMed ID: 26829886
[TBL] [Abstract][Full Text] [Related]
2. Rare sugar D-allose induces specific up-regulation of TXNIP and subsequent G1 cell cycle arrest in hepatocellular carcinoma cells by stabilization of p27kip1.
Yamaguchi F; Takata M; Kamitori K; Nonaka M; Dong Y; Sui L; Tokuda M
Int J Oncol; 2008 Feb; 32(2):377-85. PubMed ID: 18202760
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo effects of D-allose: up-regulation of thioredoxin-interacting protein in head and neck cancer cells.
Hoshikawa H; Mori T; Mori N
Ann Otol Rhinol Laryngol; 2010 Aug; 119(8):567-71. PubMed ID: 20860283
[TBL] [Abstract][Full Text] [Related]
4. Rare sugar D-allose strongly induces thioredoxin-interacting protein and inhibits osteoclast differentiation in Raw264 cells.
Yamada K; Noguchi C; Kamitori K; Dong Y; Hirata Y; Hossain MA; Tsukamoto I; Tokuda M; Yamaguchi F
Nutr Res; 2012 Feb; 32(2):116-23. PubMed ID: 22348460
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein.
Hong SY; Yu FX; Luo Y; Hagen T
Cell Signal; 2016 May; 28(5):377-383. PubMed ID: 26826652
[TBL] [Abstract][Full Text] [Related]
6. Rare sugar D-allose enhances anti-tumor effect of 5-fluorouracil on the human hepatocellular carcinoma cell line HuH-7.
Yamaguchi F; Kamitori K; Sanada K; Horii M; Dong Y; Sui L; Tokuda M
J Biosci Bioeng; 2008 Sep; 106(3):248-52. PubMed ID: 18930000
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition of head and neck carcinomas by D-allose.
Mitani T; Hoshikawa H; Mori T; Hosokawa T; Tsukamoto I; Yamaguchi F; Kamitori K; Tokuda M; Mori N
Head Neck; 2009 Aug; 31(8):1049-55. PubMed ID: 19340872
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the inhibitory mechanism of D-allose on MOLT-4F leukemia cell proliferation.
Hirata Y; Saito M; Tsukamoto I; Yamaguchi F; Sui L; Kamitori K; Dong Y; Uehara E; Konishi R; Janjua N; Tokuda M
J Biosci Bioeng; 2009 May; 107(5):562-8. PubMed ID: 19393559
[TBL] [Abstract][Full Text] [Related]
9. Rare sugar D-allose induces programmed cell death in hormone refractory prostate cancer cells.
Naha N; Lee HY; Jo MJ; Chung BC; Kim SH; Kim MO
Apoptosis; 2008 Sep; 13(9):1121-34. PubMed ID: 18622705
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the radiation effects by D-allose in head and neck cancer cells.
Hoshikawa H; Indo K; Mori T; Mori N
Cancer Lett; 2011 Jul; 306(1):60-6. PubMed ID: 21439723
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibitory effect of D-allose on human ovarian carcinoma cells in vitro.
Sui L; Dong Y; Watanabe Y; Yamaguchi F; Hatano N; Izumori K; Tokuda M
Anticancer Res; 2005; 25(4):2639-44. PubMed ID: 16080505
[TBL] [Abstract][Full Text] [Related]
12. GLUT1 regulates cell glycolysis and proliferation in prostate cancer.
Xiao H; Wang J; Yan W; Cui Y; Chen Z; Gao X; Wen X; Chen J
Prostate; 2018 Feb; 78(2):86-94. PubMed ID: 29105798
[TBL] [Abstract][Full Text] [Related]
13. Aspirin inhibits the proliferation of hepatoma cells through controlling GLUT1-mediated glucose metabolism.
Liu YX; Feng JY; Sun MM; Liu BW; Yang G; Bu YN; Zhao M; Wang TJ; Zhang WY; Yuan HF; Zhang XD
Acta Pharmacol Sin; 2019 Jan; 40(1):122-132. PubMed ID: 29925918
[TBL] [Abstract][Full Text] [Related]
14. Systemically Administered D-allose Inhibits the Tumor Energy Pathway and Exerts Synergistic Effects With Radiation.
Samukawa Y; Ouchi Y; Miyashita T; Rahman A; Tsukamoto I; Yoshihara A; Hoshikawa H
Anticancer Res; 2024 May; 44(5):1895-1903. PubMed ID: 38677730
[TBL] [Abstract][Full Text] [Related]
15. Antitumor Effects of Orally Administered Rare Sugar D-Allose in Bladder Cancer.
Tohi Y; Taoka R; Zhang X; Matsuoka Y; Yoshihara A; Ibuki E; Haba R; Akimitsu K; Izumori K; Kakehi Y; Sugimoto M
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743212
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glucose transporter 1 (GLUT1) chemosensitized head and neck cancer cells to cisplatin.
Wang YD; Li SJ; Liao JX
Technol Cancer Res Treat; 2013 Dec; 12(6):525-35. PubMed ID: 23617290
[TBL] [Abstract][Full Text] [Related]
17. Thioredoxin-interacting protein: an oxidative stress-related gene is upregulated by glucose in human prostate carcinoma cells.
Pang ST; Hsieh WC; Chuang CK; Chao CH; Weng WH; Juang HH
J Mol Endocrinol; 2009 Mar; 42(3):205-14. PubMed ID: 19052253
[TBL] [Abstract][Full Text] [Related]
18. Insulin regulates GLUT1-mediated glucose transport in MG-63 human osteosarcoma cells.
Cifuentes M; García MA; Arrabal PM; Martínez F; Yañez MJ; Jara N; Weil B; Domínguez D; Medina RA; Nualart F
J Cell Physiol; 2011 Jun; 226(6):1425-32. PubMed ID: 21321933
[TBL] [Abstract][Full Text] [Related]
19. FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression.
Shang R; Pu M; Li Y; Wang D
Oncol Rep; 2017 Apr; 37(4):2261-2269. PubMed ID: 28260073
[TBL] [Abstract][Full Text] [Related]
20. GnRH increases glucose transporter-1 expression and stimulates glucose uptake in the gonadotroph.
Harris VM; Bendre SV; Gonzalez De Los Santos F; Fite A; El-Yaman El-Dandachli A; Kurenbekova L; Abou-Samra AB; Buggs-Saxton C
J Endocrinol; 2012 Feb; 212(2):139-47. PubMed ID: 22107955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
